Impact Biomedical (IBO) Tax Provisions (2022)

Impact Biomedical (IBO) posted Tax Provisions of -$1.9 million for Q4 2022, down 249.36% on a QoQ basis from $1.3 million in Q3 2022.

Impact Biomedical (IBO) Tax Provisions (2022) Analysis & Trends

Impact Biomedical's Tax Provisions history runs 1 years deep, the most recent figure standing at -$1.9 million for Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	125,146.46
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	31.86 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	179.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Impact Biomedical	47.44 Mn	50.67 Mn	-	-

Download Data

Date	Value
Dec 31, 2022	-1.88 Mn
Sep 30, 2022	1.26 Mn